Replies to post #17280 on Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

My speculation is M923 partnership at this juncture. I'm not assigning much value to M-enoxaparin litigation or 40 mg FDA approval of M-Copax impacting any increase in PPS seen today. JMHO

[jbog]

it's making a nice positive move but the lack of volume says it means nothing at this point.

My thought was that the stock was a bargain at $13 and somewhat correctly priced at $16 without any news.